Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Gangcheng Zhang"'
Autor:
Yuling Qian, Ruilin Quan, Xiaoxi Chen, Gangcheng Zhang, Yuanhua Yang, Yucheng Chen, Zaixin Yu, Qing Gu, Changming Xiong, Huijun Han, Jianguo He
Publikováno v:
ERJ Open Research, Vol 9, Iss 6 (2023)
Background Our objective was to clarify the characteristics and long-term survival of idiopathic pulmonary arterial hypertension (IPAH) patients with thyroid dysfunction and compare them with IPAH without thyroid dysfunction. Methods A retrospective
Externí odkaz:
https://doaj.org/article/cb869498b4cf4232a019ef47512741aa
Autor:
Xintian Liu, Haojie Zhang, Wenlin Cheng, Qingkun Fan, Zhibing Lu, Xuan Zheng, Gangcheng Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Adverse effects of intravenous digoxin vary from patients and disease status, which should be closely monitored.Aims: To explore the safety profile of intravenous digoxin in acute heart failure with reduced ejection fraction (HFrEF) among
Externí odkaz:
https://doaj.org/article/b87cc03745664a0090445ba43f20998d
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-5 (2023)
Abstract The etiology of pulmonary arterial hypertension (PAH) is complex, especially the investigation of rare pathogeny is difficult. Congenital portosystemic venous shunt (CPSS) is a rare congenital anomaly in which the portal blood completely or
Externí odkaz:
https://doaj.org/article/8c3be00c851b4e6281685f1058c0ea71
Autor:
Dongling Luo, Ziyang Yang, Gangcheng Zhang, Qunshan Shen, Hongwei Zhang, Junxing Lai, Hui Hu, Jianxin He, Shulin Wu, Caojin Zhang
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Purpose The association of patent foreman ovale (PFO) and cryptogenic stroke has been studied for years. Although device closure overall decreases the risk for recurrent stroke, treatment effects varied across different studies. In this stud
Externí odkaz:
https://doaj.org/article/3bbd88ae53944503a38c94a264556394
Autor:
Shuang Leng, Ru-San Tan, Jiajun Guo, Ping Chai, Gangcheng Zhang, Lynette Teo, Wen Ruan, Tee Joo Yeo, Xiaodan Zhao, John C. Allen, Ju Le Tan, James W. Yip, Yucheng Chen, Liang Zhong
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 23, Iss 1, Pp 1-13 (2021)
Abstract Background Parameters of myocardial deformation may provide improved insights into right ventricular (RV) dysfunction. We quantified RV longitudinal myocardial function using a fast, semi-automated method and investigated its diagnostic and
Externí odkaz:
https://doaj.org/article/08a778a5f4904973ad5aec4b576f730e
Autor:
Ruilin Quan, Yuanhua Yang, Zhenwen Yang, Hongyan Tian, Shengqing Li, Jieyan Shen, Yingqun Ji, Gangcheng Zhang, Caojin Zhang, Guangyi Wang, Yuhao Liu, Zhaozhong Cheng, Zaixin Yu, Zhiyuan Song, Zeqi Zheng, Wei Cui, Yucheng Chen, Shuang Liu, Xiaoxi Chen, Yuling Qian, Changming Xiong, Guangliang Shan, Jianguo He
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background At present, there is no generally accepted comprehensive prognostic risk prediction model for medically treated chronic thromboembolic pulmonary hypertension (CTEPH) patients. Methods Consecutive medically treated CTEPH patients w
Externí odkaz:
https://doaj.org/article/6099fc8c145547d486ca698ba68c3e98
Autor:
Xiaoxian Deng, Shanshan Li, Qiu Qiu, Bowen Jin, Menghuan Yan, Yuanpin Hu, Yang Wu, Hongmei Zhou, Gangcheng Zhang, Xuan Zheng
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background Pediatric patients with genetic disorders have a higher incidence of pulmonary arterial hypertension (PAH) regardless of their heart defects. Filamin A (FLNA) mutation is recently recognized to be associated with pediatric pulmona
Externí odkaz:
https://doaj.org/article/cc2e60587a1d4f36b4b54ec1f323c73e
Autor:
Mengtao Li, Zhi-Cheng Jing, Yang Li, Yong Huo, Zaixin Yu, Gangcheng Zhang, Ping Zhu, Jinming Liu, Qiushang Ji, Bingxiang Wu, Jinhua Zhong, Pingping Wang, Wenjing Zhu, Xiaofeng Zeng
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background The efficacy and safety of ambrisentan has been previously evaluated in Chinese patients with pulmonary arterial hypertension (PAH). This post-hoc analysis assessed the efficacy and safety of ambrisentan in a subgroup of connectiv
Externí odkaz:
https://doaj.org/article/a6513411fecd401ea44be293f4bc81f4
Autor:
Hongmei Zhou, Gangcheng Zhang, Xiaoxian Deng, Bowen Jin, Qiu Qiu, Menghuan Yan, Xi Wang, Xuan Zheng
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Pulmonary hypertension is a chronic disease developing progressively with high mortality. Pulmonary hypertension patients need persistent medical care; however, limited reports focused on them when there was an outbreak of coronavirus disease 2019 in
Externí odkaz:
https://doaj.org/article/62619c2fcfd64dcda9c0c4bbb621495a
Publikováno v:
Journal of Thoracic Disease. 15:1970-1977
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::668aa5a661315a425c6a670479497f67
https://doi.org/10.21037/jtd-23-284
https://doi.org/10.21037/jtd-23-284